Search for Schering AG and
  1. March 23, 2012

    Roche cuts price of cancer drug in India

    Roche is to sharply cut the price of its cancer medicines in India, in the latest effort by a western drug company to boost...

  2. November 1, 2010

    Banks fall on bail-out burden concerns

    European banking stocks fell sharply in a broadly flat market hit by growing concerns that future sovereign bail-outs in...

  1. October 29, 2010

    Merck relies on prescription of cost-cuts

    Cost cutting and lower tax rates helped Merck, the US drugmaker, to narrowly beat Wall Street earnings estimates on Friday...

  2. October 21, 2010

    Mr Perez’s fancy footwork unsettles corporate Germany

    A decade ago, Vodafone shocked Germany by launching a blockbuster hostile bid for one of the country’s corporate icons –...

  3. August 26, 2010

    MI5 claimed Siemens a cover for Nazi spies

    Siemens, the German engineering company, was used as cover for Nazi spying and propaganda operations before and during the...

  4. November 3, 2009

    Shire hires GSK contender

    As GlaxoSmithKline boss Andrew Witty celebrates his second anniversary at the helm of the pharma group, one of his former...

  5. September 25, 2009

    FT top 50 women to watch

    Mary Armstrong, Boeing, Environmental, Health and Safety vice presidentSince 2007, previously Boeing Shared Services Group...

  6. September 21, 2009

    Merck eyes larger Merial

    Merck, the US pharmaceutical group, has given the strongest indication yet of its intention to recreate an enlarged joint...

  7. May 18, 2009

    Corporate Diary

    TODAY Shareholders meeting Schering-Plough TUESDAY 19 * Shoppers may have started cautiously buying new clothing again at...

  8. April 10, 2009

    Pharmaceuticals provide a takeover tonic

    Merger and acquisition (M&A) activity has slowed dramatically as the global financial crisis restricts the ability of...

  9. April 6, 2009

    Pharmas lack science expertise at the top

    Only one large western pharmaceutical company will be run by a scientist following completion of the current round of...

  10. April 6, 2009

    Scientists becoming an endangered species at top of drug groups

    Only one large western pharmaceutical company will be run by a scientist following completion of the current round of...

  11. April 5, 2009

    Pharmas lack science expertise at the top

    Only one large western pharmaceutical company will be run by a scientist following completion of the current round of...

  12. March 28, 2009

    J&J seeks benefits from Schering takeover

    Johnson & Johnson is preparing a push to extract concessions from Schering-Plough in exchange for allowing Merck’s planned...

  13. March 11, 2009

    Double dose

    Will mergers compensate for a broken drug discovery model? After failing to develop enough promising new medicines to make...

  14. March 10, 2009

    Drug company consolidation

    Will mergers compensate for a broken drug discovery model? After failing to develop enough promising new medicines to make...

  15. FT Alphaville

    March 10, 2009

    Merck buys Schering-Plough for $41bn

    Merck on Monday announced an agreed $41bn takeover of its New Jersey rival, Schering-Plough, just six weeks after Pfizer’s...

  16. March 4, 2009

    Bayer

    The problem with being an integrated pharmaceutical and chemicals company is deciding where you fit in. Take Bayer....

  17. March 4, 2009

    Bayer sees 'severe drop' in plastic sales

    Bayer, the German pharmaceuticals and plastics maker, said sales of plastics fell by a quarter in the last three months of...

  18. March 3, 2009

    Bayer

    The problem with being an integrated pharmaceutical and chemicals company is deciding where you fit in. Take Bayer....

  19. March 3, 2009

    Bayer sees ‘severe drop’ in plastic sales

    Bayer, the German pharmaceuticals and plastics maker, said sales of plastics fell by a quarter in the last three months of...

  20. February 1, 2009

    Banca Leonardo sees crisis openings

    Banca Leonardo, a Milan-based investment bank that is expanding rapidly across the eurozone, expects to benefit handsomely...

  21. July 22, 2008

    Drugs groups fall after Vytorin study

    Shares of drugmakers Schering-Plough and Merck fell sharply yesterday following release of a study that showed that...

  22. July 22, 2008

    Drugmakers dented by study findings

    Shares of drugmakers Schering-Plough and Merck fell sharply on Monday following release of a study that showed that Vytorin,...

  23. April 21, 2008

    Investors seek panacea from drugs industry

    Marc Rubin’s San Francisco-based biotechnology company has several interesting, though experimental, medicines in the early...

  24. March 31, 2008

    Merck and Schering-Plough

    Doctors’ negative reactions to a failed study on Vytorin, a top cholesterol-fighting drug marketed by Schering-Plough and...

  25. March 5, 2008

    US court ends patent on Bayer contraceptive

    Shares in Bayer, the German drugs and chemicals group, dropped more than 6 per cent on Tuesday after a US court overturned...

  26. March 5, 2008

    Court ends Bayer Yasmin patent

    Shares in Bayer, the German drugs and chemicals group, dropped more than 6 per cent yesterday after a US court overturned...

  27. March 5, 2008

    Court ends Bayer Yasmin patent

    Shares in Bayer, the German drugs and chemicals group, dropped more than 6 per cent yesterday after a US court overturned...

  28. March 5, 2008

    Court ends patent on Bayer contraceptive

    Shares in Bayer, the German drugs and chemicals group, dropped more than 6 per cent yesterday after a US court overturned...

  29. January 18, 2008

    Concerns over key drug hurt Schering-Plough

    Schering-Plough's shares fell 8 per cent yesterday, leaving the US drugmaker's stock 22 per cent lower for the week over...

  30. January 18, 2008

    Schering-Plough shares retreat

    Schering-Plough's shares fell 8 per cent yesterday, leaving the US drugmaker's stock 22 per cent lower for the the week due...

  31. January 18, 2008

    Concerns over key drug hurt Schering-Plough

    Schering-Plough’s shares fell 8 per cent on Thursday, leaving the US drugmaker’s stock 22 per cent lower for the week over...

  32. December 7, 2007

    Stout to quit GlaxoSmithKline

    David Stout, the head of pharmaceuticals at GlaxoSmithKline, who missed out in the race to become the new chief executive,...

  33. November 12, 2007

    Patients sought for TB drug trial

    Patient recruitment will begin this month for a groundbreaking clinical trial combining new drugs designed to reduce the...

  34. November 12, 2007

    Patients sought for TB drug trial

    Patient recruitment will begin this month for a ground-breaking clinical trial combining new drugs designed to reduce the...

  35. November 12, 2007

    Patients sought for TB drug trial

    Patient recruitment will begin this month for a groundbreaking clinical trial combining new drugs designed to reduce the...

  36. November 1, 2007

    Little room for scientists in pharma’s new generation

    Andrew Witty is in good company as he gears up to take charge of the world’s second largest pharmaceutical group next...

  37. October 24, 2007

    Merck v Schering

    Recent drug sector darling Merck won accolades this week for boosting quarterly profits above Wall Street’s already-high...

  38. October 23, 2007

    Schering profits stumble on Vytorin sales fears

    Schering-Plough yesterday was hit by the first big setback in its four-year turnround effort, when its third-quarter profit...

Search for Schering AG and